Clinical trials
Recruiting Purpura, Thrombocytopenic, Idiopathic trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
49 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 5 |
| 2024 | 12 |
| 2025 | 18 |
| 2026 | 10 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 49 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Institute of Hematology & Blood Diseases Hospital, China | 19 |
| Peking University People's Hospital | 3 |
| Takeda | 2 |
| The First Affiliated Hospital of Soochow University | 2 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2 |
| 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China | 1 |
| Anhui Provincial Hospital | 1 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 1 |
| Chinese SLE Treatment And Research Group | 1 |
| Chongqing Peg-Bio Biopharm Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Purpura, Thrombocytopenic, Idiopathic | 49 |
| Autoimmune Diseases | 4 |
| Lupus Erythematosus, Systemic | 3 |
| Purpura, Thrombocytopenic | 3 |
| Anemia, Hemolytic, Autoimmune | 2 |
| Blood Platelet Disorders | 2 |
| Cytopenia | 2 |
| Hematologic Diseases | 2 |
| Hemorrhage | 2 |
| Hemorrhagic Disorders | 2 |
Trials
Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.